OBJECTIVES The validity of bullous pemphigoid and pemphigus vulgaris recording in routinely collected healthcare data in the UK is unknown. We assessed the positive predictive value (PPV) for bullous pemphigoid and pemphigus vulgaris primary care Read codes in the Clinical Practice Research Datalink (CPRD) using linked inpatient data (Hospital Episode Statistics (HES)) as the diagnostic benchmark. SETTING:Adult participants with bullous pemphigoid or pemphigus vulgaris registered with HES-linked general practices in England between January 1998 and December 2017. Code-based algorithms were used to identify patients from the CPRD and extract their benchmark blistering disease diagnosis from HES. PRIMARY OUTCOME MEASURE The PPVs of Read co...
Background: A rising incidence and high mortality were found for bullous pemphigoid (BP) over a deca...
PURPOSE: The diagnosis of hip osteoarthritis is subject to several uncertainties, especially in pr...
Background: The BIOCHIP (Dermatology Mosaic 7, EUROIMMUN, Lubeck, Germany) is a novel multiplex indi...
Objectives: The validity of bullous pemphigoid and pemphigus vulgaris recording in routinely collect...
Introduction: Accurate use of diagnostic codes is crucial for epidemiological and genetic research b...
BACKGROUND: Trials of novel agents are required to improve the care of patients with rare diseases, ...
BackgroundTrials of novel agents are required to improve the care of patients with rare diseases, bu...
OBJECTIVE: To determine the incidence of and mortality from bullous pemphigoid and pemphigus vulgari...
This is the publisher’s final pdf. The published article is copyrighted by BioMed Central Ltd. and c...
A major obstacle in performing multicenter controlled trials for pemphigus is the lack of a validate...
Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are autoimmune blistering skin disorders which ...
Background: Bullous pemphigoid (BP) is an autoimmune blistering disorder that mainly affects older p...
A major obstacle in performing multicenter controlled trials for pemphigus is the lack of a validate...
Importance: A substantial number of patients with bullous pemphigoid do not develop skin blisters an...
Pemphigus is an autoimmune disease characterized by intraepithelial bullae and erosions in the skin ...
Background: A rising incidence and high mortality were found for bullous pemphigoid (BP) over a deca...
PURPOSE: The diagnosis of hip osteoarthritis is subject to several uncertainties, especially in pr...
Background: The BIOCHIP (Dermatology Mosaic 7, EUROIMMUN, Lubeck, Germany) is a novel multiplex indi...
Objectives: The validity of bullous pemphigoid and pemphigus vulgaris recording in routinely collect...
Introduction: Accurate use of diagnostic codes is crucial for epidemiological and genetic research b...
BACKGROUND: Trials of novel agents are required to improve the care of patients with rare diseases, ...
BackgroundTrials of novel agents are required to improve the care of patients with rare diseases, bu...
OBJECTIVE: To determine the incidence of and mortality from bullous pemphigoid and pemphigus vulgari...
This is the publisher’s final pdf. The published article is copyrighted by BioMed Central Ltd. and c...
A major obstacle in performing multicenter controlled trials for pemphigus is the lack of a validate...
Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are autoimmune blistering skin disorders which ...
Background: Bullous pemphigoid (BP) is an autoimmune blistering disorder that mainly affects older p...
A major obstacle in performing multicenter controlled trials for pemphigus is the lack of a validate...
Importance: A substantial number of patients with bullous pemphigoid do not develop skin blisters an...
Pemphigus is an autoimmune disease characterized by intraepithelial bullae and erosions in the skin ...
Background: A rising incidence and high mortality were found for bullous pemphigoid (BP) over a deca...
PURPOSE: The diagnosis of hip osteoarthritis is subject to several uncertainties, especially in pr...
Background: The BIOCHIP (Dermatology Mosaic 7, EUROIMMUN, Lubeck, Germany) is a novel multiplex indi...